Search Results 731-740 of 16669 for supplement stack optimization

  1. Study to Analyze Olanzapine With or Without Fosaprepitant Dimeglumine in Preventing Chemotherapy Induced Nausea and Vomiting in Cancer Patients Receiving Highly Emetogenic Chemotherapy - Mayo Clinic

    Drugs & Supplements A-Z · Health Books · Healthy Living Program · Mayo Clinic Health ... optimal dosages and risks/benefits. In the later phase (phase 3) ...

  2. Ultrasound Evaluation of Crohn's Disease - Mayo Clinic

    Drugs & Supplements A-Z · Health Books · Healthy Living Program · Mayo Clinic Health ... optimal dosages and risks/benefits. In the later phase (phase 3) ...

  3. Lu AF82422 in participants with Multiple System Atrophy - Mayo Clinic

    Drugs & Supplements A-Z · Health Books · Healthy Living Program · Mayo Clinic Health ... optimal dosages and risks/benefits. In the later phase (phase 3) ...

  4. Efficacy and Safety of Riociguat in Patients With Systemic Sclerosis - Mayo Clinic

    Drugs & Supplements A-Z · Health Books · Healthy Living Program · Mayo Clinic Health ... optimal dosages and risks/benefits. In the later phase (phase 3) ...

  5. A Study to Evaluate Trifluridine/Tipiracil Combined with Bevacizumab vs Trifluridine/Tipiracil to Treat Patients with Refractory Metastatic Colorectal Cancer - Mayo Clinic

    Drugs & Supplements A-Z · Health Books · Healthy Living Program · Mayo Clinic Health ... optimal dosages and risks/benefits. In the later phase (phase 3) ...

  6. Oncology (Medical) - Clinical trials

    Drugs & Supplements · Healthy Lifestyle · Mayo Clinic Health Letter & Books. For ... The purpose of this study is to improve patient care by optimizing and ...

  7. A Study Of The Effect, Safety, And Tolerability Of LJPC-501 In Patients With Catecholamine-Resistant Hypotension - Mayo Clinic

    Drugs & Supplements A-Z · Health Books · Healthy Living Program · Mayo Clinic Health ... optimal dosages and risks/benefits. In the later phase (phase 3) ...

  8. SUPRAME-ACTengine® IMA203 Vs. Investigator's Choice Of Treatment In Previously Treated, Unresectable Or Metastatic Cutaneous Melanoma - Mayo Clinic

    During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3) ...

  9. A Study to Test the Addition of Nivolumab to Chemotherapy to Treat Soft Tissue Sarcoma - Mayo Clinic

    Drugs & Supplements A-Z · Health Books · Healthy Living Program · Mayo Clinic Health ... optimal dosages and risks/benefits. In the later phase (phase 3) ...

  10. A Study to Assess the Safety and Tolerability of Single and Multiple Doses of KAN-101 in Celiac Disease Patients - Mayo Clinic

    Drugs & Supplements A-Z · Health Books · Healthy Living Program · Mayo Clinic Health ... optimal dosages and risks/benefits. In the later phase (phase 3) ...